GACP awarded to Licensed Producer AgMedica Bioscience Inc.

GACP awarded to Licensed Producer AgMedica Bioscience Inc.

News image

GACP awarded to Licensed Producer AgMedica Bioscience Inc.


Chatham, Ontario – March 18, 2021 - AgMedica Bioscience Inc. ("AgMedica"), a licensed producer of cannabis is delighted to announce the granting of the Good Agricultural and Collection Practices (GACP) certification by the Control Union Medical Cannabis Standard (CUMCS) for meeting their guidelines for consistency and quality in the cultivation and harvest of cannabis. The CUMCS-GAP standard serves as a practical manual for Good Agricultural Practice (GAP) of medical cannabis throughout in the world.


CUMCS-GAP has been benchmarked against the Israeli Medical Cannabis Standard (IMC-GAP) and is a recognized and accepted program under the Israeli Medical Cannabis Agency (IMCA). The CUMCS certification standard is based on GACP guidelines of the World Health Organization (WHO), the GACP Guidelines of the European Medicines Agency (EMA GACP), Guidelines of the Dutch Government for Cannabis for Medical Use and the International Standard for Good Agriculture Practice.


“We are delighted to achieve this internationally recognized certification that speaks to both the market leading quality of our operation as well as the rigor of our practices and marks another important milestone in the continued evolution of our business” stated AgMedica CEO Dr. Trevor Henry.


About AgMedica Bioscience Inc.

As a licensed producer of medicinal and recreational cannabis, AgMedica is dedicated to becoming a global leader in the development and commercialization of cannabis and cannabis-derived products to support the health and wellness of our clients across all channels. We aspire to drive the evolution of the cannabis industry by focusing investment on the development and commercialization of differentiated products in the medicinal, health & wellness and pharmaceutical sectors as well as providing the highest possible quality to recreational channels. For further information, please visit our website at


For media or other inquiries, please contact:

AgMedica Bioscience Inc.

Dr. Trevor Henry

Chief Executive Officer

P: 1-844-247-4633




This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. These risks and uncertainties include, but are not limited to, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.


Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.